Antibody drug conjugates (ADC) that bind to 161P2F10B proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9308278
APP PUB NO 20140194601A1
SERIAL NO

14106444

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antibody drug conjugates (ADC's) that bind to 161P2F10B protein are described herein. 161P2F10B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AGENSYS INC2375 WATERVIEW DRIVE NORTHBROOK IL 60062

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
An, Zili Santa Monica, US 23 118
Gudas, Jean Los Angeles, US 50 659
Jakobovits, Aya Beverly Hills, US 288 8747
Morrison, Robert Kendall Santa Monica, US 90 568
Torgov, Michael Santa Monica, US 53 594

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 12, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00